The peroxisome proliferator-activated receptor-γ agonist rosiglitazone increases bone resorption in women with type 2 diabetes: A randomized, controlled trial

Ugis Gruntmanis, Steve Fordan, Hans K. Ghayee, Shuaib M Abdullah, Raphael See, Colby R. Ayers, Darren K McGuire

Research output: Contribution to journalArticlepeer-review

45 Scopus citations

Fingerprint

Dive into the research topics of 'The peroxisome proliferator-activated receptor-γ agonist rosiglitazone increases bone resorption in women with type 2 diabetes: A randomized, controlled trial'. Together they form a unique fingerprint.

Medicine & Life Sciences